Intravascular Imaging Increases Cost-Effectiveness of Coronary Artery Procedures: AHA

Written By : Jacinthlyn Sylvia |Medically Reviewed By : Dr. Kamal Kant Kohli Published On 2024-03-26T21:00:12+05:30 | Updated On 27 March 2024 9:36 AM IST

A recent study unveiled the cost-effectiveness of intravascular imaging-guided percutaneous coronary intervention (PCI) compared to conventional angiography-guided procedures. The findings were published in Circulation: Cardiovascular Quality and Outcomes reveal significant benefits for patients with complex coronary artery lesions.

The RENOVATE-COMPLEX-PCI trial was conducted in Korea from May 2018 to May 2021 and examined the clinical and economic outcomes of employing intravascular imaging during PCI procedures. This randomized controlled trial involved a total of 1639 patients and utilized a Markov model to simulate various health states over a 3-year and lifetime horizon.

The results from this research showed compelling evidence in favor of intravascular imaging-guided PCI. Over the 3-year follow-up period, the patients who underwent this advanced technique experienced higher quality-adjusted life years (QALY) and incurred slightly greater medical costs when compared to the individuals who underwent angiography-guided PCI. The incremental cost-effectiveness ratio (ICER) within the trial data stood at $57,040 per QALY gained that fell within the threshold of $35,000 per QALY.

Despite initial higher costs, the long-term analysis revealed a reversal in cumulative medical expenses between the two groups. The patients who underwent intravascular imaging-guided PCI enjoyed consistently higher QALY and also incurred lower total cumulative medical costs that resulted in a dominant incremental cost-effectiveness ratio.

Overall, this study suggests that intravascular imaging-guided PCI is not only clinically beneficial but also more cost-effective in the management of complex coronary artery lesions over the long term. This advanced imaging technology optimizes patient outcomes while minimizing healthcare expenditures by reducing medical costs and improving quality of life.

Reference:

Hong, D., Lee, J., Lee, H., Cho, J., Guallar, E., Choi, K. H., Lee, S. H., Shin, D., Lee, J.-Y., Lee, S.-J., Lee, S. Y., Kim, S. M., Yun, K. H., Cho, J. Y., Kim, C. J., Ahn, H.-S., Nam, C.-W., Yoon, H.-J., … Park, Y. H. (2024). Cost-Effectiveness of Intravascular Imaging-Guided Complex PCI: Prespecified Analysis of RENOVATE-COMPLEX-PCI Trial. In Circulation: Cardiovascular Quality and Outcomes. Ovid Technologies (Wolters Kluwer Health). https://doi.org/10.1161/circoutcomes.123.010230

Circulation: Cardiovascular Quality and Outcomespercutaneous coronary interventionCoronary artery procedure

Source : Circulation: Cardiovascular Quality and Outcomes

Jacinthlyn Sylvia

Neuroscience Masters graduate

Jacinthlyn Sylvia, a Neuroscience Master's graduate from Chennai has worked extensively in deciphering the neurobiology of cognition and motor control in aging. She also has spread-out exposure to Neurosurgery from her Bachelor’s. She is currently involved in active Neuro-Oncology research. She is an upcoming neuroscientist with a fiery passion for writing. Her news cover at Medical Dialogues feature recent discoveries and updates from the healthcare and biomedical research fields. She can be reached at editorial@medicaldialogues.in

Dr. Kamal Kant Kohli

Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751